MABp1 to improve clinical outcomes of patients with symptomatic refractory metastatic colorectal cancer patients: Per-protocol population analysis of phase III study (P1026).
Authors: Wyrwicz, L., Hickish, T. et al.
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 35
eISSN: 1527-7755
ISSN: 0732-183X
DOI: 10.1200/JCO.2017.35.15_suppl.3530
Source: Web of Science (Lite)